Your browser doesn't support javascript.
The potential impact of the COVID-19 pandemic on global antimicrobial and biocide resistance: an AMR Insights global perspective.
Ansari, Shamshul; Hays, John P; Kemp, Andrew; Okechukwu, Raymond; Murugaiyan, Jayaseelan; Ekwanzala, Mutshiene Deogratias; Ruiz Alvarez, Maria Josefina; Paul-Satyaseela, Maneesh; Iwu, Chidozie Declan; Balleste-Delpierre, Clara; Septimus, Ed; Mugisha, Lawrence; Fadare, Joseph; Chaudhuri, Susmita; Chibabhai, Vindana; Wadanamby, J M Rohini W W; Daoud, Ziad; Xiao, Yonghong; Parkunan, Thulasiraman; Khalaf, Yara; M'Ikanatha, Nkuchia M; van Dongen, Maarten B M.
  • Ansari S; Department of Microbiology, Chitwan Medical College and Teaching Hospital, Bharatpur, 44200 Chitwan, Nepal.
  • Hays JP; Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Centre Rotterdam (Erasmus MC), Rotterdam, The Netherlands.
  • Kemp A; Scientific Advisory Board of the British Institute of Cleaning Sciences, Northampton, UK.
  • Okechukwu R; Department of Clinical Pharmacy and Pharmacy Management, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Agulu Campus, Nigeria.
  • Murugaiyan J; Department of Biology, SRM University AP, Andhra Pradesh 522502, India.
  • Ekwanzala MD; Department of Environmental, Water and Earth Sciences, Tshwane University of Technology, Pretoria, South Africa.
  • Ruiz Alvarez MJ; Environmental Engineering, Department of Civil Engineering, Kyung Hee University, Yongin-si, Gyeonggi-do, Republic of Korea.
  • Paul-Satyaseela M; Research Coordination and Support Service, Istituto Superiore di Sanità, Rome, Italy.
  • Iwu CD; Acharya Institute of Technology, Bengaluru, India.
  • Balleste-Delpierre C; School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
  • Septimus E; ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
  • Mugisha L; Department of Population Medicine, Harvard Medical School & Harvard Pilgrim Health Care Institute, Boston, MA, 02215, Texas A&M College of Medicine, Houston, TX 77030, USA.
  • Fadare J; College of Veterinary Medicine, Animal Resources & Biosecurity (COVAB), Makerere University, Kampala, Uganda.
  • Chaudhuri S; Department of Pharmacology and Therapeutics, College of Medicine, Ekiti State University, Ado-Ekiti, Nigeria.
  • Chibabhai V; Translational Health Science and Technology Institute, Faridabad 121001, India.
  • Wadanamby JMRWW; Department of Clinical Microbiology and Infectious Diseases, University of the Witwatersrand, and Clinical Microbiology Laboratory, Charlotte Maxeke Johannesburg Academic Hospital, National Health Laboratory Service, Johannesburg, South Africa.
  • Daoud Z; Department of Microbiology, Lanka Hospital Diagnostics, Lanka Hospital 578, Elvitigala Mw, Colombo 05, Sri Lanka.
  • Xiao Y; Department of Clinical Microbiology & Infection Prevention, Michigan Health Clinics-Saginaw, MI, USA and Department of Foundational Sciences, CMED-CMU, Mount Pleasant, MI, USA.
  • Parkunan T; State Key Laboratory for Diagnosis & Treatment of Infectious Diseases, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 300013, China.
  • Khalaf Y; Department of Veterinary Physiology and Biochemistry, Faculty of Veterinary and Animal Sciences, Institute of Agricultural Sciences, Rajiv Gandhi South Campus, Banaras Hindu University, Mirzapur, Uttar Pradesh, India.
  • M'Ikanatha NM; Department of Epidemiology, High Institute of Public Health, Alexandria University, Alexandria, Egypt.
  • van Dongen MBM; Division of Infectious Disease Epidemiology, Pennsylvania Department of Health, Harrisburg, PA, USA.
JAC Antimicrob Resist ; 3(2): dlab038, 2021 Jun.
Article in English | MEDLINE | ID: covidwho-1288048
ABSTRACT
The COVID-19 pandemic presents a serious public health challenge in all countries. However, repercussions of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections on future global health are still being investigated, including the pandemic's potential effect on the emergence and spread of global antimicrobial resistance (AMR). Critically ill COVID-19 patients may develop severe complications, which may predispose patients to infection with nosocomial bacterial and/or fungal pathogens, requiring the extensive use of antibiotics. However, antibiotics may also be inappropriately used in milder cases of COVID-19 infection. Further, concerns such as increased biocide use, antimicrobial stewardship/infection control, AMR awareness, the need for diagnostics (including rapid and point-of-care diagnostics) and the usefulness of vaccination could all be components shaping the influence of the COVID-19 pandemic. In this publication, the authors present a brief overview of the COVID-19 pandemic and associated issues that could influence the pandemic's effect on global AMR.
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study Topics: Vaccines Language: English Journal: JAC Antimicrob Resist Year: 2021 Document Type: Article Affiliation country: Jacamr

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study Topics: Vaccines Language: English Journal: JAC Antimicrob Resist Year: 2021 Document Type: Article Affiliation country: Jacamr